Clinical and immunological significance of HLA-E in stem cell transplantation and cancer (Q38270003)

1 September 2017

1 reference

title

Clinical and immunological significance of HLA-E in stem cell transplantation and cancer (English)

1 reference

1 September 2017

1 reference

L Wieten

1

1 reference

1 September 2017

N M Mahaweni

2

1 reference

1 September 2017

C E M Voorter

3

1 reference

1 September 2017

G M J Bos

4

1 reference

1 September 2017

M G J Tilanus

5

1 reference

1 September 2017

publication date

1 December 2014

1 reference

1 September 2017

1 reference

1 September 2017

volume

84

1 reference

1 September 2017

issue

6

1 reference

1 September 2017

page(s)

523-535

1 reference

A structural perspective on MHC class Ib molecules in adaptive immunity

1 September 2017

cites work

1 reference

The other Janus face of Qa-1 and HLA-E: diverse peptide repertoires in times of stress

21 January 2018

1 reference

The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.

21 January 2018

1 reference

Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E

21 January 2018

1 reference

A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition

21 January 2018

1 reference

Clinical significance of the HLA-E and CD94/NKG2 interaction

21 January 2018

1 reference

HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities

21 January 2018

1 reference

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

21 January 2018

1 reference

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

21 January 2018

1 reference

MicroRNA editing facilitates immune elimination of HCMV infected cells

21 January 2018

1 reference

Transcriptional and posttranscriptional regulations of the HLA-G gene

21 January 2018

1 reference

Differential microRNA regulation of HLA-C expression and its association with HIV control

21 January 2018

1 reference

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues

21 January 2018

1 reference

Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.

21 January 2018

1 reference

Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution

21 January 2018

1 reference

Oncogenic stress sensed by the immune system: role of natural killer cell receptors

21 January 2018

1 reference

HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer

21 January 2018

1 reference

Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.

21 January 2018

1 reference

Effects of Peptide on NK cell-mediated MHC I recognition

21 January 2018

1 reference

TCR specificity dictates CD94/NKG2A expression by human CTL.

21 January 2018

1 reference

CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.

21 January 2018

1 reference

Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

21 January 2018

1 reference

The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors

21 January 2018

1 reference

HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes

21 January 2018

1 reference

Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine

21 January 2018

1 reference

HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells

21 January 2018

1 reference

Analysis of regulatory CD8 T cells in Qa-1-deficient mice

21 January 2018

1 reference

HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes

21 January 2018

1 reference

Characterization of HLA-E polymorphism in four distinct populations in Mainland China

21 January 2018

1 reference

Definitive high resolution typing of HLA-E allelic polymorphisms: Identifying potential errors in existing allele data

21 January 2018

1 reference

HLA-E polymorphism in Amerindians from Mexico (Mazatecans), Colombia (Wayu) and Chile (Mapuches): evolution of MHC-E gene

21 January 2018

1 reference

Population genetic studies of HLA-E: evidence for selection.

21 January 2018

1 reference

Worldwide HLA-E nucleotide and haplotype variability reveals a conserved gene for coding and 3' untranslated regions.

21 January 2018

1 reference

Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells

21 January 2018

1 reference

Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation

21 January 2018

1 reference

Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.

21 January 2018

1 reference

Association of HLA-E polymorphism with the outcome of hematopoietic stem-cell transplantation with unrelated donors.

21 January 2018

1 reference

HLA-E polymorphisms in hematopoietic stem cell transplantation.

21 January 2018

1 reference

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function

21 January 2018

1 reference

Endothelial cells in allograft rejection

21 January 2018

1 reference

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

Targeting HLA class I expression to increase tumor immunogenicity

21 January 2018

1 reference

Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells

21 January 2018

1 reference

HLA-E polymorphism in patients with nasopharyngeal carcinoma.

21 January 2018

1 reference

Lack of association between human leukocyte antigen-E alleles and nasopharyngeal carcinoma in Tunisians.

21 January 2018

1 reference

HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression

21 January 2018

1 reference

HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes.

21 January 2018

1 reference

Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands

21 January 2018

1 reference

Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer

21 January 2018

1 reference

Plasma levels of soluble HLA-E and HLA-F at diagnosis may predict overall survival of neuroblastoma patients

21 January 2018

1 reference

Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells.

21 January 2018

1 reference

21 January 2018

The Protein Data Bank

1 reference

The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling

21 January 2018

1 reference

SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information

21 January 2018

1 reference

Protein structure homology modeling using SWISS-MODEL workspace.

21 January 2018

1 reference

Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective.

21 January 2018

1 reference

Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance?

21 January 2018

1 reference

Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells.

21 January 2018

1 reference

High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis

21 January 2018

1 reference

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients.

21 January 2018

1 reference

NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect

21 January 2018

1 reference

Lack of association between HLA-E polymorphisms and transitional cell carcinoma of the bladder.

21 January 2018

1 reference

Signal sequences: more than just greasy peptides

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TAN.12478

1 reference

1 September 2017

1 reference